WallStreetZenWallStreetZen

NASDAQ: PBM
Psyence Biomedical Revenue

OverviewEarningsRevenue
DividendOwnership
Psyence Biomedical revenue was $0.00 for the trailing 12 months ending Mar 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2024) ending on Mar 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, PBM annual revenue was $0.0, with N/A growth year-over-year.

PBM revenue history

Current Revenue
$0.0
Current Earnings
-$51.2M
Current Profit Margin
0%

Be the first to know when PBM announces revenue.

PBM Revenue History By Year

PBM Yearly RevenuePBM RevenuePBM ChangePBM Revenue Growth
2024-03-31$0.00N/AN/A
2023-03-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Psyence Biomedical Revenue FAQ

What was PBM's revenue last quarter?

Psyence Biomedical (NASDAQ: PBM) reported Q1 2024 revenue of N/A up N/A year over year. In the same quarter last year, Psyence Biomedical's revenue was $0.00.

What was Psyence Biomedical's revenue in 2024?

Psyence Biomedical's annual revenue for the twelve months ending Mar 31, 2024 was $0.00, a N/A decrease year over year.

How much does Psyence Biomedical make in a day?

Based on Psyence Biomedical annual revenue for the past three years, PBM makes an average of $0.00 per day.

What was Psyence Biomedical's annual revenue growth in the past year?

As of Q2 2025, Psyence Biomedical's revenue has grown null year over year. Psyence Biomedical's revenue in the past year totaled $0.00.

How much does Psyence Biomedical make in a year?

Psyence Biomedical's revenue by year for the past three years is:
  • Psyence Biomedical's revenue for the twelve months ending Mar 31, 2024 was $0.00, a N/A decrease year over year.
  • Psyence Biomedical's annual revenue for Mar 31, 2023 was $0.00, a N/A decrease from 2022.
  • Psyence Biomedical's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.